Literature DB >> 11782497

Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis.

Dominique Swennen1, Marie-Françoise Paul, Laurence Vernis, Jean-Marie Beckerich, Alain Fournier, Claude Gaillardin.   

Abstract

Yarrowia lipolytica and Kluyveromyces lactis secretion vectors were constructed and assessed for the expression of heterologous proteins. An anti-Ras single-chain antibody fragment (scFv) coding sequence was fused in-frame to different pre- or prepro-regions, or downstream from a reporter secretory gene (Arxula adeninivorans glucoamylase), separated by a Kex2 protease (Kex2p)-like processing sequence. Both organisms are able to secrete soluble scFv, with yields depending on the nature of the expression cassette, up to levels ranging from 10 to 20 mg l(-1). N-terminal sequence analysis of the purified scFv showed that fusions are correctly processed to the mature scFv by a signal peptidase or a Kex2p-type endoprotease present in Y. lipolytica and K. lactis. The scFv protein also retains the capacity to bind to a glutathioneS-transferase (GST)-Harvey-Ras(Val12) fusion, indicating that the antibody is functional. These results indicate that the yeasts Y. lipolytica and K. lactis have potential for industrial production of soluble and active scFv.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782497     DOI: 10.1099/00221287-148-1-41

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  Involvement of a branched-chain aminotransferase in production of volatile sulfur compounds in Yarrowia lipolytica.

Authors:  Daniela Cernat Bondar; Jean-Marie Beckerich; Pascal Bonnarme
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

Review 2.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

3.  Improved production of heterologous proteins by a glucose repression-defective mutant of Kluyveromyces lactis.

Authors:  Claudia Donnini; Francesca Farina; Barbara Neglia; Maria Concetta Compagno; Daniela Uccelletti; Paola Goffrini; Claudio Palleschi
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

4.  Heterologous expression and optimized production of an Aspergillus aculeatus endo-1,4-beta-mannanase in Yarrowia lipolytica.

Authors:  Robyn Roth; Venessa Moodley; Petrus van Zyl
Journal:  Mol Biotechnol       Date:  2009-06-09       Impact factor: 2.695

5.  The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.

Authors:  Vivi Joosten; Christien Lokman; Cees AMJJ Van Den Hondel; Peter J Punt
Journal:  Microb Cell Fact       Date:  2003-01-30       Impact factor: 5.328

6.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

7.  Heterologous expression of an α-amylase inhibitor from common bean (Phaseolus vulgaris) in Kluyveromyces lactis and Saccharomyces cerevisiae.

Authors:  Stephanie Brain-Isasi; Alejandro Álvarez-Lueje; Thomas Joseph V Higgins
Journal:  Microb Cell Fact       Date:  2017-06-15       Impact factor: 5.328

Review 8.  Synthetic biology tools for engineering Yarrowia lipolytica.

Authors:  M Larroude; T Rossignol; J-M Nicaud; R Ledesma-Amaro
Journal:  Biotechnol Adv       Date:  2018-10-11       Impact factor: 14.227

9.  Yarrowia lipolytica vesicle-mediated protein transport pathways.

Authors:  Dominique Swennen; Jean-Marie Beckerich
Journal:  BMC Evol Biol       Date:  2007-11-12       Impact factor: 3.260

10.  Secretion of a low and high molecular weight β-glycosidase by Yarrowia lipolytica.

Authors:  Paul Swietalski; Frank Hetzel; Ines Seitl; Lutz Fischer
Journal:  Microb Cell Fact       Date:  2020-05-11       Impact factor: 5.328

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.